The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic β-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. (7th February 2018)

• Record Type: Journal Article
• Authors: Mooranian, Armin; Takechi, Ryu; Jamieson, Emma; Morahan, Grant; Al-Salami, Hani
• Is Part Of: Pharmaceutical development and technology. Volume 23:Number 2(2018)
• Page Start: 145
• Page End: 150
• Publication Date: 2018-02-07
• Subjects: Artificial cell microencapsulation -- MIN6 -- diabetes mellitus -- biomaterials -- polymer; Drug delivery systems -- Periodicals; Pharmaceutical technology -- Periodicals; Drugs -- Administration -- Research -- Periodicals; Drug Delivery Systems -- Periodicals; Pharmaceutical Preparations -- Periodicals; Technology, Pharmaceutical -- Periodicals; 615
• DOI: 10.1080/10837450.2017.1321664
• Languages: English
• ISSNs: 1083-7450

Abstract

Abstract: Introduction: Ideal cell-containing microcapsules should be capable of maintaining cell viability and exhibit significant structural stability to support cellular functionality. To date, such microcapsules remain unavailable; thus, this study used our well-established microencapsulating methods to examine a total of 32 different microencapsulating formulations and correlate polymers' molecular weights ( M wt ) and UDCA addition, with cell viability and microcapsules' stability, postmicroencapsulation. Methods: MIN6 mouse-cloned pancreatic β-cells were microencapsulated using control ( n = 16; without UDCA) and test ( n = 16; with UDCA) different polymers. Confocal microscopic imaging, cell viability, and microcapsules' stability were assessed. Results: Best cell viability (>50%) was obtained at average M wt of 50, 000 g/mol (poly-l -ornithine), followed by 110, 000 g/mol (poly-l -lysine). There was no linear correlation between M wt and viability. Confocal imagining showed similar microcapsules' shape and cell distribution among all different polymers' molecular weights, which suggests that the microencapsulating method was efficient and maintained microcapsules' uniformity. UDCA addition resulted in enhanced osmotic stability of the microcapsules and improved cell viability, when the formulation contained 1% polylornithine, 1% polyethylene glycol, 20% Eudragit ® NM30D, 1% polytetrafluoroethylene, or 5% pentamethylcyclopentasiloxane. Conclusions: UDCA addition improved microenvironmental conditions within the microcapsules but this effect was largely dependent on the polymer systems used.